BPI
HAE icon

BFC Planning, Inc.’s Haemonetics HAE Stock Holding History

BFC Planning, Inc.’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$900 Buy
+12
New +$771 ﹤0.01% 3169

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

BFC Planning, Inc.'s HAE Position: Q2 2026 in Review

BFC Planning, Inc. opened a new position in Haemonetics (HAE) in Q2 2026: 12 shares worth $900. The stake represents ﹤0.01% of the portfolio and ranks #3169 among its holdings.

332 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • BFC Planning, Inc. held 12 shares of Haemonetics worth $900 as of Q2 2026.
  • Haemonetics was a new BFC Planning, Inc. position in Q2 2026.
  • Haemonetics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3169 holding.
  • 332 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.